GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Enbrel® | Rhu Tnfr:Fc | TNFR-Fc | TNR 001
                                 etanercept is an approved drug (FDA (1998), EMA (2000)) Compound class: 
                                                            Peptide
                                 
                                    
                                        Comment: Etanercept is a TNFα inhibitor. It is a dimeric recombinant protein fusing the TNF receptor 2 (TNFRSF1B) to the Fc region of the human IgG1 antibody. Etanercept is used as a disease-modifying anti-rheumatic drug (DMARD). Biosimilars: 
   View more information in the IUPHAR Pharmacology Education Project: etanercept | 
| Classification  | |
| Compound class | Peptide | 
| Approved drug? | Yes. US FDA (1998) | EU EMA (2000) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 7783 | etanercept | 
| Synonyms  | 
| Enbrel® | Rhu Tnfr:Fc | TNFR-Fc | TNR 001 | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 216 | 
| Other databases | |
| CAS Registry No. | 185243-69-0 | 
| ChEMBL Ligand | CHEMBL1201572 | 
| DrugBank Ligand | DB00005 | 
| GtoPdb PubChem SID | 178103395 | 
| PubChem SID | 135343504 | 
| Search PubMed clinical trials | etanercept | 
| Search PubMed titles | etanercept | 
| Search PubMed titles/abstracts | etanercept | 
| Wikipedia | Etanercept |